Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
5.29
-0.52 (-8.95%)
Mar 31, 2025, 4:00 PM EDT - Market closed

Recursion Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Cash & Equivalents
594.35391.57549.91285.12262.13
Upgrade
Short-Term Investments
---231.45-
Upgrade
Cash & Short-Term Investments
594.35391.57549.91516.56262.13
Upgrade
Cash Growth
51.79%-28.79%6.46%97.07%275.09%
Upgrade
Accounts Receivable
---0.030.16
Upgrade
Other Receivables
49.173.092.759.06-
Upgrade
Receivables
49.173.092.759.090.16
Upgrade
Restricted Cash
3.053.231.281.552
Upgrade
Other Current Assets
67.7140.2515.877.512.16
Upgrade
Total Current Assets
714.27438.14569.81534.72266.44
Upgrade
Property, Plant & Equipment
233.21120.17121.4564.7325.97
Upgrade
Goodwill
148.8752.060.80.80.8
Upgrade
Other Intangible Assets
335.8636.441.311.391.69
Upgrade
Long-Term Deferred Tax Assets
1.93----
Upgrade
Other Long-Term Assets
14.456.897.928.723.69
Upgrade
Total Assets
1,449653.7701.29610.35298.59
Upgrade
Accounts Payable
21.613.954.592.821.07
Upgrade
Accrued Expenses
80.2841.7630.2927.6710.49
Upgrade
Current Portion of Long-Term Debt
0.110.040.10.091.07
Upgrade
Current Portion of Leases
22.116.125.95--
Upgrade
Current Unearned Revenue
61.7736.4356.731010
Upgrade
Other Current Liabilities
1.594.872.626.080.47
Upgrade
Total Current Liabilities
187.4793.17100.2746.6623.1
Upgrade
Long-Term Debt
0.681.10.540.6311.41
Upgrade
Long-Term Leases
85.5943.4144.42--
Upgrade
Long-Term Unearned Revenue
118.7751.2470.266.6716.67
Upgrade
Long-Term Deferred Tax Liabilities
16.581.34---
Upgrade
Other Long-Term Liabilities
4.73--13.455.38
Upgrade
Total Liabilities
413.82190.26215.4867.4156.56
Upgrade
Common Stock
0000-
Upgrade
Additional Paid-In Capital
2,4741,4311,125943.147.31
Upgrade
Retained Earnings
-1,431-967.62-639.56-400.08-213.6
Upgrade
Comprehensive Income & Other
-7.64---0.13-
Upgrade
Total Common Equity
1,035463.44485.81542.94-206.29
Upgrade
Shareholders' Equity
1,035463.44485.81542.94242.02
Upgrade
Total Liabilities & Equity
1,449653.7701.29610.35298.59
Upgrade
Total Debt
108.4950.6751.010.7212.49
Upgrade
Net Cash (Debt)
485.86340.89498.91515.84249.64
Upgrade
Net Cash Growth
42.52%-31.67%-3.28%106.63%335.00%
Upgrade
Net Cash Per Share
1.771.642.844.1211.46
Upgrade
Filing Date Shares Outstanding
401.99234.65191.23170.7722.31
Upgrade
Total Common Shares Outstanding
396.8234.27191.02170.2722.31
Upgrade
Working Capital
526.8344.97469.55488.06243.34
Upgrade
Book Value Per Share
2.611.982.543.19-9.24
Upgrade
Tangible Book Value
550.05374.94483.7540.75-208.78
Upgrade
Tangible Book Value Per Share
1.391.602.533.18-9.36
Upgrade
Machinery
128.2982.2267.6953.0820.78
Upgrade
Construction In Progress
2.713.238.7516.451.36
Upgrade
Leasehold Improvements
72.7345.9341.8713.9413.79
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q